CHV
Overview
Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs. They focus on investment opportunities within the healthcare and life science markets, specifically medical technologies including medical devices, diagnostics, drug delivery, and digital health. They are typically the first institutional investor and support companies through early product and clinical development and often through the regulatory process.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sera Prognostics Inc. | Feb 2015 | Grant | Co-investor |
| Instylla | Aug 2023 | Series C | Co-investor |
| AtaCor Medical | Apr 2024 | Series C | Co-investor |
| Aria CV | Feb 2020 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CHV based?
CHV is headquartered in Boston, Massachusetts, United States.
When was CHV founded?
CHV was founded in 2008.
How many portfolio companies does CHV have?
CHV has 5 portfolio companies in Caplight's dataset.
What are some companies in CHV's portfolio?
Portfolio companies visible on Caplight include Sera Prognostics Inc., Instylla, AtaCor Medical, Aria CV.
What was CHV's most recent investment shown here?
CHV's most recent investment in this portfolio sample was in AtaCor Medical in 2024.
What sectors does CHV focus on?
CHV focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does CHV focus on?
CHV typically invests at the Mid stage.
What is CHV's AUM?
CHV's assets under management are estimated between $100.0M and $250.0M.